Q4 2018 BioDelivery Sciences International Inc Earnings Call
שיחת ועידה BioDelivery Sciences International Inc
BioDelivery Sciences International Inc Conference call will be held on 14/03/2019. During the earnings conference call's session BioDelivery Sciences International Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact BioDelivery Sciences International Inc for this information
Schedule an online conference with QCONF conference service and get 5 free calls with online conferencing.
We are a specialty pharmaceutical company that is developing and commercializing, either on our own or in partnerships with third parties, new applications of approved therapeutics to address important unmet medical needs using both proven and new drug delivery technologies. We have developed and are continuing to develop pharmaceutical products aimed principally in the areas of pain management and addiction. We were incorporated in the State of Indiana in 1997 and were reincorporated as a Delaware corporation in 2002. Our approved products utilize the novel, patent protected and proprietary BioErodible MucoAdhesive (or BEMA®) drug delivery technology, a small, erodible polymer film for application to the buccal mucosa (the lining inside the cheek). Our first U.S.קרא עוד שיחת ועידה